Apyx Medical Stock Forecast

Stock Price Forecast

The 4 analysts that cover Apyx Medical stock have a consensus rating of "Strong Buy" and an average price target of $6.50, which forecasts a 76.15% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $8.00.

Price Target: $6.50 (+76.15%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$6.50	$6.00	$8.00
Change	+62.60%	+76.15%	+62.60%	+116.80%

Analyst Ratings

The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	0	0	1	1	1	3
Buy	1	1	1	1	1	1
Hold	2	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	1	2	2	2	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $5 → $6	Strong Buy	Maintains	$5 → $6	+62.60%	Mar 11, 2026
Sam Eiber BTIG	BTIG	Hold → Strong Buy Upgrades $6	Hold → Strong Buy	Upgrades	$6	+62.60%	Mar 11, 2026
Kyle Bauser Roth Capital	Roth Capital	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+62.60%	Dec 16, 2025
David Turkaly Citizens	Citizens	Hold → Buy Upgrades $8	Hold → Buy	Upgrades	$8	+116.80%	Nov 12, 2025
Sam Eiber BTIG	BTIG	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Oct 17, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

59.14M

from 52.84M

11.92%

from 52.84M

Revenue Next Year

65.11M

from 59.14M

10.08%

from 59.14M

EPS This Year

-0.37

from -0.27

EPS Next Year

-0.34

from -0.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	48.52M	44.51M	52.35M	48.10M	52.84M	59.14M	65.11M
Revenue Growth	75.08%	-8.26%	17.61%	-8.11%	9.86%	11.92%	10.08%
EPS	-0.44	-0.67	-0.54	-0.66	-0.27	-0.37	-0.34
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	61.2M	69.0M
Avg	59.1M	65.1M
Low	56.4M	60.5M

Revenue Growth

Revenue Growth	2026	2027
High	15.8%	16.6%
Avg	11.9%	10.1%
Low	6.8%	2.4%

EPS Forecast

EPS	2026	2027
High	-0.32	-0.29
Avg	-0.37	-0.34
Low	-0.41	-0.37

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.